Avalyn Pharma Inc. Common Stock
AVLN | NASDAQ
$25.63
-$0.08 (-0.31%)
At close: Oct 30, 2026, 4:00 PM ET
$25.18
-$0.45 (-1.76%)
After-hours:
Oct 30, 2026, 7:30 PM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 |
|---|---|
Cash & Equivalents | 52.32M |
Short-Term Investments | 86.04M |
Long-Term Investments | n/a |
Other Long-Term Assets | 3M |
Receivables | 537K |
Inventory | n/a |
Other Current Assets | n/a |
Total Current Assets | 143.56M |
Property-Plant & Equipment | 2.32M |
Goodwill & Intangibles | n/a |
Total Long-Term Assets | 5.32M |
Total Assets | 148.88M |
Account Payables | 3.76M |
Deferred Revenue | n/a |
Short-Term Debt | n/a |
Other Current Liabilities | 4.29M |
Total Current Liabilities | 14.09M |
Long-Term Debt | n/a |
Other Long-Term Liabilities | 372.22M |
Total Long-Term Liabilities | 373.45M |
Total Liabilities | 387.54M |
Total Debt | 1.67M |
Book Value | -238.66M |
Book Value Per Share | -5.71 |
Common Stock | 24K |
Retained Earnings | -265.36M |
Comprehensive Income | 134K |
Shareholders Equity | -238.66M |
Total Investments | 86.04M |
Add to Watchlist
Select watchlists to add or remove AVLN